Same active ingredient
Both forms contain semaglutide, but they are absorbed through different routes.
Switching guide
If you currently use Wegovy injections and are considering the Wegovy tablet, switching may be possible after a clinical review. The right approach depends on your current dose, how well you tolerate treatment and whether a daily tablet routine suits you.
Wegovy injections and tablets contain the same active ingredient, semaglutide, but the medicine is absorbed differently. Your prescriber will help decide the most appropriate tablet strength and timing.

Both forms contain semaglutide, but they are absorbed through different routes.
Your current dose, progress and side effects should be checked before switching.
The injection is weekly, while the tablet needs a consistent morning routine.
Many patients may be able to switch from Wegovy injections to Wegovy tablets, provided it is clinically suitable. This can be more straightforward than changing from a different weight loss medicine because both forms contain semaglutide.
The main difference is how the medicine enters your body. The injection is absorbed through tissue under the skin, while the tablet passes through the digestive system.
Some patients may be able to start the tablet when their next injection would have been due. However, the exact plan should be confirmed by a prescriber, especially if you have side effects, recent dose changes or medical concerns.
Do not stop Wegovy injections or move to tablets without speaking to a qualified healthcare professional first.
Because you are already using semaglutide, you may not need to restart at the lowest tablet dose. However, injection strengths and tablet strengths are not matched milligram for milligram because the body absorbs them differently.
Your prescriber will decide the closest suitable tablet strength based on your current injection dose, how long you have been taking it and how well you tolerate treatment.
Current dose
Wegovy injection
Possible switch
Wegovy pill
0.25mg
4mg
0.5mg
4mg
1mg
9mg
1.7mg
9mg
2.4mg
25mg
This table is for guidance only. If you are experiencing side effects, your prescriber may recommend a lower tablet strength instead of the closest equivalent.
Since you are continuing semaglutide rather than stopping treatment completely, switching should not usually cause sudden weight regain when managed correctly.
Wegovy tablets and injections are expected to support a similar weight management pathway when the tablet is taken correctly and the dose is clinically appropriate. However, some people may notice changes in appetite control or side effects because the delivery method is different.
Common side effects can include nausea, constipation, diarrhoea, bloating, stomach discomfort and reduced appetite. If symptoms become severe or difficult to manage, speak to your prescriber.
This is often the biggest practical change. Wegovy injections are taken once weekly, so once your injection day is set, there is usually less daily planning.
The Wegovy tablet needs more consistency. It should be taken correctly each day so your body can absorb the medicine properly.
Take it first thing in the morning
Take it on an empty stomach
Use a small amount of water
Wait at least 30 minutes before food, drink or other medicines
Some patients prefer tablets because they avoid injections. Others may find a weekly injection easier than following strict tablet instructions every morning.
If you are losing weight, tolerating treatment and do not mind using injections, changing format may offer limited benefit.
The tablet requires a consistent morning routine. It may be less suitable if you regularly eat, drink or take medicines immediately after waking.
Switching format does not guarantee side effects will disappear. Your prescriber may need to adjust your dose or review whether treatment remains suitable.
Switching from Wegovy injections to tablets may be straightforward for some patients, but the best option depends on your dose, treatment response, side effects and lifestyle. A prescriber can help you decide whether switching is suitable.
To support ongoing medicine safety monitoring, suspected side effects can be reported through the MHRA Yellow Card scheme.